Press Release, Lund November 17, 2020 Hamlet Pharma AB has secured patent protection in Europe for milk-based nutraceutical products that have been prepared using a…
Read More
Pressmeddelande, Lund 29 oktober, 2020 Aktieägarna i Hamlet Pharma AB, 556568-8958, kallas härmed till årsstämma torsdagen den 26 november 2020 kl. 15.00 i Plenisalen, High…
Press Release, Lund October 23, 2020 The kick-off meeting for a recently funded European Union Horizon 2020 project titled ‘HAMLET-BC: A Unique Bladder Cancer Therapeutic,…
Press Release, Lund October 6, 2020 BAMLET (bovine α-lactalbumin made lethal to tumour cells) is a molecular complex formed by bovine α-lactalbumin and oleic acid….
Press Release, Lund September 25, 2020 Hamlet Pharma is pleased to announce that the clinical development of Alpha1H therapy in bladder cancer will be accelerated….
Press Release, Lund September 4, 2020 The board of Hamlet Pharma has decided to accept a proposal from Linnane Pharma to terminate the patent license…
Press Release, Lund June 12, 2020 Hamlet Pharma is proud to announce that the contract with the European union has been signed, granting pre-payment of…
Press Release, Lund May 12, 2020 A patent licensing agreement has been signed between Hamlet Pharma AB and Linnane Pharma AB to secure the development…
Newsletter 2020 – Issue 2; Business Update – Hamlet Pharma receives EU grant for €2.2M Last month, members of the Hamlet Pharma Executive Team travelled…
Newsletter 2020 – Issue 1; Bladder Cancer “Bladder cancer (BC) has the highest lifetime treatment costs per patient (pp) of all cancers, followed by colorectal-,…
Press Release, Lund February 5, 2020 Alpha1H shows significant promise as a new and effective cancer drug with low toxicity in a clinical bladder cancer…
Pressmeddelande, Lund 3 februari, 2020 Hamlet Pharma tillförs 12,95 miljoner SEK genom inlösen av teckningsoptioner utfärdade i samband med den riktade emissionen från den 1…